Ever since the seminal first balloon angioplasy in a young patient with angina pectoris on 16 September 1977 by the late Andreas R. Grüntzig at the University Hospital Zurich,1 interventional cardi-ology has contributed importantly to the rise of cardiovascularmedi-cine.2With the advent of drug-eluting stents, restenosis has become less important,3 butwhetherornot it affectshardoutcomes including mortality, or represents a clinical nuisance only is still a matter of debate.Whetherwe really use percutaneous coronary interventions (PCIs) only in those patients who truly need it has also been ques-tioned by many critics of current clinical practice.4 Finally, although primary PCI has become the standard of care in acute coronary syndromes (AC...